Pfizer raised its revenue outlook for the year on higher-than-expected sales from its Covid-19 vaccine despite reporting a drop in third-quarter revenue on.wsj.com
@WSJ3 years ago
A Pfizer executive said the Covid-19 vaccine supply chain that developed at the height of the pandemic provides a model for rolling out lifesaving drugs on.wsj.com
@WSJ3 years ago
Pfizer-BioNTech vaccines modified to target Omicron produced stronger immune responses in study subjects than the original Covid-19 shot, the companies say on.wsj.com
@WSJ3 years ago
Pfizer has asked the FDA to authorize its Covid-19 vaccine in children 6 months to 5 years. The three-dose series could be available later this month. on.wsj.com
@WSJ3 years ago
Pfizer asked the FDA to authorize its Covid-19 booster dose for children 5 to 11 years old. The agency is expected to take a couple of weeks to conduct its review, a person familiar with the matter said. on.wsj.com
@nytimesworld3 years ago
Pfizer agreed to sell up to four million treatment courses of its Covid pills for use in 95 lower-income countries. The pills, set to be available next month, will most likely be the first Covid drugs available in some of the poorest parts of the world. nyti.ms
@guardian3 years ago
Covid live: South Korea approves Pfizer vaccine for five-year-olds; UK emergency loan losses hit £16bn theguardian.com
@guardian3 years ago
Pfizer predicts bumper year from Covid vaccine and pill as profits double theguardian.com
@WSJ3 years ago
Breaking: The U.S. cleared use of a Covid-19 pill from Pfizer, the first drug that newly infected patients can now take at home to stay out of the hospital on.wsj.com
@WSJ3 years ago
Pfizer and BioNTech have asked U.S. regulators to fully approve their Covid-19 vaccine for 12- to 15-year-olds on.wsj.com
@WSJ3 years ago
People who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found on.wsj.com
@guardian3 years ago
Australia confirms five- to 11-year-old children approved to receive Pfizer Covid vaccine – video theguardian.com
@WSJ2 years ago
Pfizer said it expects to price its Covid-19 vaccine at $110 to $130 a dose for adults when the U.S. government stops purchases on.wsj.com
@WSJ3 years ago
Pfizer and BioNTech began tinkering with their Covid-19 vaccine before new Omicron strains spread in the U.S. The preparations are a big reason the reformulated boosters are rolling out now. on.wsj.com
@WSJ3 years ago
Children as young as six months could get Covid-19 shots as soon as Monday after vaccines from Pfizer and Moderna were cleared for use by the FDA on.wsj.com
@WSJ3 years ago
Here is what parents should know about Covid-19 vaccines and children after Pfizer and BioNTech said three doses of their shot generated a strong immune response and were 80% effective in children 6 months to 5 years https://on.wsj.com/3yT7jl6
@WSJ3 years ago
Vaccine makers Pfizer and Moderna have both named company outsiders as chief financial officers as the companies look to deploy some of the cash they generated during the Covid-19 pandemic https://on.wsj.com/3rgxsWk
@WSJ3 years ago
Pfizer has a deal to sell to Unicef the company’s Covid-19 pill Paxlovid. Unicef plans to provide it to 95 low- and middle-income countries https://on.wsj.com/3L0HQsQ
@WSJ3 years ago
The FDA has asked for more time to decide whether to expand authorization of the Pfizer-BioNTech Covid-19 vaccine to children under 5 years, saying it wants to consider more data https://on.wsj.com/3sDbQ6m
@guardian3 years ago
Pfizer seeks US authorization of Covid vaccine for children under five https://www.theguardian.com/world/2022/feb/01/fda-urges-pfizer-to-apply-for-authorization-of-covid-vaccine-for-children-under-five?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1643763155
@WSJ3 years ago
CDC advisers recommended adults take Pfizer or Moderna Covid vaccines over Johnson & Johnson’s due to a risk of rare clotting cases tied to the J&J shot https://on.wsj.com/3p4oET3
@WSJ3 years ago
CDC advisers recommended adults take Pfizer or Moderna Covid vaccines over Johnson & Johnson’s due to a risk of rare clotting cases tied to the J&J shot https://on.wsj.com/3IZEZ3o
@WSJ3 years ago
Omicron was able to elude two doses of the Covid-19 vaccine from Pfizer and BioNTech in initial lab testing, but three doses neutralized the variant, the companies said https://on.wsj.com/3pHYPXV
@guardian3 years ago
Covid news live: England moves to ‘plan B’; three Pfizer shots can ‘neutralise’ Omicron, lab tests show https://www.theguardian.com/world/live/2021/dec/09/covid-news-live-england-moves-to-plan-b-three-pfizer-shots-can-neutralise-omicron-lab-tests-show?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1639010824
@WSJ2 years ago
Novavax’s Covid-19 vaccine was authorized by the FDA as a booster for adults who don’t want or can’t access or might have medical reasons to avoid the dual-target booster shots from Pfizer or Moderna https://on.wsj.com/3yQBicQ
@WSJ3 years ago
Pfizer is taking steps to maintain its blockbuster Covid-19 product sales, but there were warning signs in the company’s guidance and the rest of the business might not offer much cushion https://on.wsj.com/3oIWziR
@WSJ3 years ago
Children as young as six months could get Covid-19 shots as soon as Monday after vaccines from Pfizer and Moderna were cleared for use by the FDA https://on.wsj.com/3HwtGiu
@guardian3 years ago
Pfizer accused of Covid profiteering as first-quarter sales hit $26bn https://www.theguardian.com/business/2022/may/03/pfizer-covid-sales-pricing-vaccine-paxlovid-pill?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1651585691
@WSJ3 years ago
The CDC backed giving second Covid-19 booster shots from Pfizer and Moderna to adults 50 years and older. Health regulators are expected to authorize the additional shots for the broader population in the fall. https://on.wsj.com/3Lo8WKD
@WSJ3 years ago
Pfizer asked the FDA to authorize a second booster dose of its Covid-19 vaccine for people 65 years and older. Regulators are expected to decide in time for the Biden administration to begin a potential fall vaccine campaign. https://on.wsj.com/3JeLdMn
@WSJ3 years ago
The FDA is expected to release its review of the Pfizer-BioNTech Covid-19 vaccine for children under age 5 as soon as Friday https://on.wsj.com/3LDF1zh
@WSJ3 years ago
Pfizer asked the FDA to authorize its Covid vaccine in children under 5. A booster is under study, as two doses produced a weak immune response in some kids. https://on.wsj.com/3JcvvB9
@WSJ3 years ago
Pfizer pushed back plans to seek authorization of its Covid vaccine in children 2 to 5 years old, after a weaker-than-expected immune response in a study https://on.wsj.com/3yD79MB
@WSJ3 years ago
The first large real-world study of how vaccines hold up against Omicron found that two shots of Pfizer and BioNTech’s Covid-19 vaccine lowered the risk of hospital admission by 70% for patients infected with the highly mutated variant https://on.wsj.com/3EUN72H
@WSJ3 years ago
People who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found https://on.wsj.com/3EVzgJu
@BBCWorld3 years ago
Booster Covid jabs promising against Omicron variant, Pfizer and BioNTech say https://bbc.in/3EGaxsk
@WSJ3 years ago
Pfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years https://on.wsj.com/3dNgVpC
@WSJ3 years ago
Pfizer has asked the FDA to approve its Covid pill Paxlovid, a move toward selling the drug commercially, rather than only to the federal government as currently allowed https://on.wsj.com/3a4z9kk
@WSJ3 years ago
Covid vaccines from Pfizer and Moderna were recommended for kids as young as 6 months by FDA advisers. It's the last major group waiting for the shots. https://on.wsj.com/3MWGdx1
@WSJ3 years ago
Investors voted down shareholder proposals urging Pfizer, Moderna and Johnson & Johnson to broaden global access to their Covid-19 vaccines https://on.wsj.com/38y8cEP
@WSJ3 years ago
Second Covid-19 booster shots from Pfizer and Moderna have been authorized by the FDA for adults 50 years and older https://on.wsj.com/38c0tMn
@WSJ3 years ago
Pfizer expects results from its study of the Covid-19 drug Paxlovid in high-risk children by the end of the year https://on.wsj.com/360ua1O
@WSJ3 years ago
Pfizer said surging sales of its Covid-19 treatment and continued demand for its shots should boost the company’s revenue to around $100 billion this year https://on.wsj.com/3ryj6RV
@WSJ3 years ago
The Food and Drug Administration gave its full approval to Moderna's Covid-19 vaccine, branded Spikevax, for use in adults 18 and older, making it the second fully approved Covid-19 vaccine after one from Pfizer and BioNTech https://on.wsj.com/3udpQpU
@guardian3 years ago
T-cells in Pfizer Covid jab recipients stay robust against severe illness https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1639761325
@nytimesworld3 years ago
Pfizer said on Tuesday that trials of its Covid pill confirmed that it helped stave off severe disease. A lab study found it worked against Omicron. https://nyti.ms/3pVSYOP
@WSJ3 years ago
Omicron was able to elude two doses of the Covid-19 vaccine from Pfizer and BioNTech in initial lab testing, but three doses neutralized the variant, the companies said https://on.wsj.com/3rRov6X
@guardian3 years ago
Covid live: UK reports 51,342 new infections; three Pfizer shots can ‘neutralise’ Omicron, lab tests show https://www.theguardian.com/world/live/2021/dec/08/covid-live-news-south-korea-surge-sparks-hospital-alarm-stealth-omicron-variant-found?CMP=twt_gu&utm_source=Twitter&utm_medium#Echobox=1638981019